Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy

Published:2024-08-27 Issue:36 Volume:16 Page:47270-47283
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhang Min¹²,Zhao Yifan¹,Lv Bai¹,Jiang Huimei¹,Li Zequn³,Cao Jie¹^ORCID

Affiliation:

1. School of Pharmacy, Qingdao University, Qingdao 266071, China

2. Institute of Biomedical Materials and Engineering, College of Materials Sciences and Engineering, Qingdao University, Qingdao 266071, China

3. Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China

Funder

Taishan Scholar Project of Shandong Province

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.4c09925

Reference51 articles.

1. The Changing Landscape of Therapeutic Cancer Vaccines—Novel Platforms and Neoantigen Identification

2. Therapeutic cancer vaccines

3. Vaccine-like nanomedicine for cancer immunotherapy

4. Cancer vaccines: the next immunotherapy frontier

5. Biomaterial‐Based In Situ Cancer Vaccines

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP